The settlement between Cordis and Boston Scientific announced in February 2010 is the second agreement between the companies following a long running dispute. The litigation started several years ago as a result of disputed patents in the field of stents.

The litigation was pending in a court in Delaware and involved several coronary stent products including Cordis’ Cypher and Boston’s Liberte, Taxus Liberte and Taxus Express. The current settlement provides for a total payment of $1.725 billion to Cordis.

This is the second settlement agreement announced between the parties in the past year. An earlier settlement between the companies in September 2009 worth $716 million covered Boston’s NIR stent.

These settlements do not affect other litigation including Cordis lawsuits against boston Scientific’s Promus stent products.